EPM2A Protein (AA 1-331) (His tag)

Produktnummer ABIN1621302

Produktdetails

Target: EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))

Protein-Typ: Recombinant

Proteineigenschaft: AA 1-331

Spezies: Hund

Quelle: Hefe

Aufreinigungstag / Konjugat: Dieses EPM2A Protein ist gelabelt mit His tag.

Applikation: ELISA

Sequenz: MRFRFGVVVP PAGAGAAPEL LVVGSRPELG RWEPRGAVRL RPAGSAAGGG ARALQEPGLW LGEVELAPGE AARDGAEPAR VDTFWYKFLK REPGGALSWE GNGPHHDRCC TYNENNLVDG VYCLPIGHWI EATGHTNEMK HTTDFYFNIA GHQAMHYSRI LPNIWLGSCP RQVEHITIKL KHELGITAVM NFQTEWDIVQ NSSGCNRYPE PMTPDTMIKL YKEEGLVYIW MPTPDMSTEG RVQMLPQAVC LLHALLENGH TVYVHCNAGV GRSTAAVCGW LQYVMGWNLR KVQYFLMAKR PAVYIDEDAL ARAEEDFFQK FGKVRSSVCS V

Spezifität: Canis familiaris (Dog) (Canis lupus familiaris)

Produktmerkmale: Please inquire if you are interested in this recombinant protein expressed in E. coli, mammalien cells or by baculovirus infection. Be aware about differences in price and lead time.

Reinheit: > 90 %

Anwendungsinformationen

Kommentare:

The yeast protein expression system is the most economical and efficient eukaryotic system for secretion and intracellular expression. A protein expressed by the mammalian cell system is of very high-quality and close to the natural protein. But the low expression level, the high cost of medium and the culture conditions restrict the promotion of mammalian cell expression systems. The yeast protein expression system serve as a eukaryotic system integrate the advantages of the mammalian cell expression system. A protein expressed by yeast system could be modificated such as glycosylation, acylation, phosphorylation and so on to ensure the native protein conformation. It can be used to produce protein material with high added value that is very close to the natural protein. Our proteins produced by yeast expression system has been used as raw materials for downstream preparation of monoclonal antibodies.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: 0.2-2 mg/mL

Buffer: Tris-based buffer, 50 % glycerol

Handhabung: Repeated freezing and thawing is not recommended. Store working aliquots at 4 °C for up to one week

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20 °C, for extended storage, conserve at -20 °C or -80 °C.

Antigendetails

Target: EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))

Andere Bezeichnung: Laforin (EPM2A) (EPM2A Produkte)

Synonyme: TG-B Protein, Tg(TcraK,TcrbK)TG-BFlv Protein, EPM2 Protein, MELF Protein, laforin Protein, EPM2A, laforin glucan phosphatase Protein, epilepsy, progressive myoclonic epilepsy, type 2 gene alpha Protein, EPM2A Protein, Epm2a Protein

Hintergrund: Recommended name: Laforin.
EC= 3.1.3.16.
EC= 3.1.3.48.
Alternative name(s): Lafora PTPase.
Short name= LAFPTPase

UniProt: Q1M199

Pathways: Cellular Glucan Metabolic Process